start portlet menu bar end portlet menu bar

Vaccination against Staphylococcal biofilm for the prevention of subclinical mastitis in manchega sheep in Spain

Inicio Conocimiento Vaccination against Staphylococcal biofilm for the prevention of subclinical mastitis in manchega sheep in Spain

Vaccination against Staphylococcal biofilm for the prevention of subclinical mastitis in manchega sheep in Spain


Subclinical mastitis has an important economic impact on dairy sheep farms mainly because of milk production losses and high replacement costs.

Descarga este artículo

1,71 MB

Sobre este artículo

Apareció en

International Sheep Veterinary Congress, 2017

Fecha

26 may. 2017

Autores

Sanz, M. A.; Calvo, T; Medrano, J. I.

Resumen

Since the use of VIMCO® there has been a decrease in the BTSCC (20%). VIMCO® is a tool that we can include with other preventive measures to avoid the transmission of staphylococci on dairy sheep farms. This will contribute to the control of subclinical mastitis on the farm, improving the profitability of the farm, reducing the use of antibiotics and increasing milk quality.

Servicios relacionados

HIPRA Diagnos

Productos relacionados

VIMCO®

Publicaciones relacionadas

Efficacy of vaccination against biofilm-producing staphylococci as a preventive measure against subclinical mastitis in lacaune and manchega sheep in Spain Reduction of bulk tank somatic cell count (BTSCC) after vaccination with a biofilm-producing Staphylococcal mastitis vaccine in a dairy sheep flock in Spain Evaluation of the impact of vaccination against Staphylococcal mastitis in milk yield in assaf ewes in Spain

Compartir en

start portlet menu bar

Vaccination against Staphylococcal biofilm for the prevention of subclinical mastitis in manchega sheep in Spain

Display portlet menu
end portlet menu bar

Ver también

Publicaciones

Efficacy of vaccination against biofilm-producing staphylococci as a preventive measure ag...

11-06-2018
Fichas de enfermedades

Mastitis in small ruminants

12-01-2017
Noticia

HIPRA participa en el foro ovino con el foco sobre las mastitis subclínicas

05-07-2018